U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H13N4O8P
Molecular Weight 348.206
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of INOSINIC ACID

SMILES

O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N2C=NC3=C2N=CNC3=O

InChI

InChIKey=GRSZFWQUAKGDAV-KQYNXXCUSA-N
InChI=1S/C10H13N4O8P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1

HIDE SMILES / InChI

Molecular Formula C10H13N4O8P
Molecular Weight 348.206
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro.
2009-01-01
Multiple receptor systems for glutamate detection in the taste organ.
2008-10
Predicting the sensitivity and specificity of published real-time PCR assays.
2008-09-25
Identification and characterization of two trypanosome TFIIS proteins exhibiting particular domain architectures and differential nuclear localizations.
2008-09
Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3.
2008-09
Effects of dietary inosinic acid on carcass characteristics, meat quality, and deposition of inosinic acid in broilers.
2008-07
Chemical and genetic validation of dihydrofolate reductase-thymidylate synthase as a drug target in African trypanosomes.
2008-07
Expression of caffeine biosynthesis genes in tea (Camellia sinensis).
2008-06-07
Estimation of genetic parameters for contents of intramuscular fat and inosine-5'-monophosphate and carcass traits in Chinese Beijing-You chickens.
2008-06
C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection.
2008-06
The plasma ammonia response to cycle exercise in COPD.
2008-04
Kinetic studies on the reactions of [Pd(dach)(X-Y)] complexes with some DNA constituents.
2008-02-14
Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.
2008-01
IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.
2008-01
The proteome of Toxoplasma gondii: integration with the genome provides novel insights into gene expression and annotation.
2008
Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.
2007-11-01
A motif-based search in bacterial genomes identifies the ortholog of the small RNA Yfr1 in all lineages of cyanobacteria.
2007-10-17
Characterization of retinal inosine monophosphate dehydrogenase 1 in several mammalian species.
2007-10-03
IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance.
2007-10
Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.
2007-09
Formamide as the main building block in the origin of nucleic acids.
2007-08-16
Sources of umami taste in Cheddar and Swiss cheeses.
2007-08
Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice.
2007-08
Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419).
2007-07-26
Oxidation of chylomicron remnant-like particles inhibits their uptake by THP-1 macrophages by apolipoprotein E-dependent processes.
2007-07
Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.
2007-06-26
TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules.
2007-04-15
Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model.
2007-04-10
Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor.
2007-02-01
Why do mutations in the ubiquitously expressed housekeeping gene IMPDH1 cause retina-specific photoreceptor degeneration?
2006-09
Detection of eight antibodies in cancer patients' sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis.
2006-06-21
Structure of SAICAR synthase from Thermotoga maritima at 2.2 angstroms reveals an unusual covalent dimer.
2006-04-01
The nucleotide derivatives inosine and inosinic acid inhibit intestinal absorption of mizoribine in rats.
2006-02-15
Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.
2006
Creatine supplementation reduces muscle inosine monophosphate during endurance exercise in humans.
2005-12
Competitive reactions of L-methionine and 5'-GMP towards platinum (II) complexes.
2005-11
[Genetic parameter estimation for inosine-5-monophosphate and intramuscular fat contents and other meat quality traits in chicken muscle].
2005-11
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.
2005-10-15
Indications of mycophenolate mofetil in liver transplantation.
2005-09-27
Stoichiometric estimates of the biochemical conversion efficiencies in tsetse metabolism.
2005-08-05
Polyinosinic acid induces TNF and NO production as well as NF-kappaB and AP-1 transcriptional activation in the monocytemacrophage cell line RAW 264.7.
2005-08
Study of the reactions between platinum(II) complexes and L-methionine in the presence and absence of 5'-GMP.
2005-07
Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.
2005-06
Dynamic simulation of red blood cell metabolism and its application to the analysis of a pathological condition.
2005-05-09
Guanylic nucleotide starvation affects Saccharomyces cerevisiae mother-daughter separation and may be a signal for entry into quiescence.
2005-05-04
Data mining of the transcriptome of Plasmodium falciparum: the pentose phosphate pathway and ancillary processes.
2005-03-18
Interferon: ten stories in one. A short review of some of the highlights in the history of an almost quinquagenarian.
2005
Mechanisms of action of mycophenolate mofetil.
2005
Ageing and immunosuppression in kidney transplantation.
2004-12
Acid phosphatase/phosphotransferases from enteric bacteria.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:30:59 GMT 2025
Edited
by admin
on Mon Mar 31 20:30:59 GMT 2025
Record UNII
TAO7US05G5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
INOSINIC ACID
MI  
Common Name English
CYTOSINE INOSINATE
WHO-DD  
Preferred Name English
INOSINIC ACID [MI]
Common Name English
INOSINIC ACID, 5'-
Common Name English
IMP
Common Name English
HYPOXANTHINE RIBOSIDE-5-PHOSPHORIC ACID
Common Name English
Cytosine inosinate [WHO-DD]
Common Name English
INOSINE 5'-(DIHYDROGEN PHOSPHATE)
Systematic Name English
E-630
Code English
INOSINE PHOSPHATE
Common Name English
5'-IMP
Common Name English
INS NO.630
Code English
INS-630
Code English
INOSINE-5'-MONOPHOSPHORIC ACID
Common Name English
5'-INOSINIC ACID
Systematic Name English
Classification Tree Code System Code
CODEX ALIMENTARIUS (GSFA) INS-630
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
JECFA EVALUATION INS-630
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
DSLD 474 (Number of products:10)
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
Code System Code Type Description
DRUG BANK
DB04566
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-045-1
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY
EVMPD
SUB128911
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY
CHEBI
17202
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY
SMS_ID
100000154449
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY
MERCK INDEX
m6290
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY Merck Index
EVMPD
SUB13527MIG
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY
EPA CompTox
DTXSID80948097
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY
FDA UNII
TAO7US05G5
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY
RXCUI
5832
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY RxNorm
PUBCHEM
135398640
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY
CAS
131-99-7
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY
WIKIPEDIA
INOSINIC ACID
Created by admin on Mon Mar 31 20:30:59 GMT 2025 , Edited by admin on Mon Mar 31 20:30:59 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY